DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates
DaVita (DVA) announced that the Center for Medicare and Medicaid Innovation (CMMI) has extended its Kidney Care Choices (KCC) Model for an additional year.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Positive
- Extension of the Kidney Care Choices Model indicates program success and government support
- Doubled value-based care arrangements from 11 to 22 Kidney Contracting Entities
- Improved patient outcomes including increased transplantation and home dialysis rates
- Large established presence with 3,173 outpatient dialysis centers serving 282,000 patients globally
Negative
- None.
Details
News Market Reaction – DVA
The recorded move for DVA in the trading session of this news was -0.05%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
"As a dedicated participant in the government's value-based care initiative and a pioneer in this field for the last twenty years, we applaud CMMI's decision to extend the Kidney Care Choices (KCC) Model for an additional year. We believe the investments made by CMMI and participants alike will result in long-term savings in the upcoming years. The program's emphasis on comprehensive, collaborative care and patient engagement is driving encouraging health outcomes. DaVita is committed to establishing a new standard for kidney care through integrated care systems alongside our nephrology partners."
Together with participating nephrologists, DaVita launched 11 value-based care arrangements in 2022 and has since doubled that footprint to 22 Kidney Contracting Entities (KCEs). A recent report demonstrates that these value-based care arrangements result in increased transplantation, more patients dialyzing with an optimal access in place, and more patients dialyzing at home.
To learn more about DaVita Integrated Kidney Care programs, visit DaVita.com/Innovation.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of March 31, 2025, DaVita served approximately 282,000 patients at 3,173 outpatient dialysis centers, of which 2,661 centers were located in the United States and 512 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Media Contact
View original content:https://www.prnewswire.com/news-releases/davita-statement-on-governments-kidney-care-choices-kcc-model-updates-302469731.html
SOURCE DaVita
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.